Home   Chapter Home   Jobs   Conferences   Fellowships   Books

 

 

 

 

Breast-malignant, males, children

Breast cancer - spread and metastases

 

Author: Nat Pernick, M.D, PathologyOutlines.com, Inc.

Reviewer: Daniel Visscher, M.D., University of Michigan Hospitals, February 2009 (see Reviewers page)

Revised: 12 April 2010

Last major update: September 2009

Copyright: (c) 2002-2010, PathologyOutlines.com, Inc.

 

Local spread

=========================================================================

● To skin or chest wall

● Nipple invasion more common if tumors are within 2.5 cm of nipple

● Local recurrence after surgery appears as nodules, often near old scar, but can be simulated by post-surgical granulomas

 

Nodal metastases

=========================================================================

● Axilla is most common site of nodal metastases

● Also supraclavicular and internal mammary region

 

Distant metastases

=========================================================================

● Common sites are adrenal gland, bone (desmoplasia may cause dry taps in bone marrow), central nervous system (more often basal-like phenotype - high grade, CK 5/6+, EGFR+, ER negative, Am J Surg Pathol 2006;30:1097), liver, lung/pleura (often mammaglobin+, Mod Pathol 2007;20:208), ovary (60-80% are bilateral, are GCDFP-15+)

● Lobular carcinoma tends to metastasize to abdominal/pelvic cavities including GI tract, ovaries and serosal surfaces

 

Occult primary

=========================================================================

● If enlarged axillary node contains carcinoma, but no breast mass or other tumor is detected clinically or radiologically, usually a primary breast carcinoma will eventually be found in adjacent breast, although it may be very small (usually < 2 cm)

● Radiation therapy may be adequate therapy for patients with occult primary (Oncology 2006;71:456)

Melanomas may also present with occult primary

● Metastatic breast carcinomas to GI tract are usually positive for GCDFP-15 (78%), ER (72%), CK5/6 (61%); also PR (33%), androgen receptors and HER2; negative for CDX2 and CK20 (Archives 2005;129:338)

● Androgen receptor nuclear staining suggests breast or ovarian primary (Diagn Pathol 2006;1:34)

 

Case reports of metastatic sites

=========================================================================

● Colonic polyp (Archives 1984;108:318)

● Endometrial polyp (Case of the Week #125)

● Liver (Archives 2004;128:1418)

● Lung causing cor pulmonale (Archives 1986;110:1197)

● Ovarian granulosa cell tumor (Hum Pathol 2002;33:445)

● Stomach #1 (Archives 2001;125:567), #2 (World J Surg Oncol 2007;5:75)

● Thyroid follicular adenoma (Archives 1994;118:551)

 

Gross images

=========================================================================

 

Liver-hepar lobatum (irregular nodularity, usually due to either

tertiary syphilis or metastatic tumor)

 

Micro images

=========================================================================

 

Breast cancer metastases

                               

To cervix                                                                               Source: AFIP

 

To endometrial polyp (below)

                                 

 

                               

ER                                           PR                                           GCDFP-15

 

To jaw-mandible

 

                                               

To liver

 

                               

To lung #1                             #2-various stains               #3-mammaglobin expression (Fig d)

 

               

To oral cavity #1                 #2

 

To ovarian granulosa cell tumor

 

               

To skin #1                             #2 - tumor is p63 negative

 

                                               

To stomach                          H&E and stains                   H&E and stains                   ER+, PR+, GCDFP-15+

 

               

To stomach                          ER+

 

               

To thyroid                             Lobular carcinoma and entrapped

                                                thyroid follicles (AFIP)

 

                                                               

Thyroid - ER stains breast tumor but not                     False positive thyroglobulin stain due

papillary thyroid carcinoma (AFIP)                                 to diffusion from trapped follicles and

                                                                                                nonspecific absorption (AFIP)

 

Other images:

                                               

Androgen receptor+ ductal,                            Androgen receptor

lobular and ovarian carcinoma                       stains nuclei

 

Virtual slides

=========================================================================

 

Metastases to heart

 

Positive stains in unknown primary

=========================================================================

● GCDFP-15, lactalbumin, ER and PR staining are relatively specific for breast primary

● Breast carcinoma is usually CK7+/CK20- (also carcinomas of lung and ovary, but GI, pancreaticobiliary and some ovarian tumors are CK20+)

● Mammaglobulin in more sensitive but less specific than GCDFP-15 (AJCP 2007;127:103)

 

Markers to distinguish specific primaries

=========================================================================

Breast vs. lung: GCDFP-15 (breast) and TTF-1 (lung)

Breast vs. ovary: GCDFP-15 (breast) and WT1 (ovary) (Am J Surg Pathol 2004;28:1076), although breast mucinous carcinomas may also be WT1+ (Mod Pathol 2008;21:1217)

 

Differential diagnosis

=========================================================================

● Sarcoidosis may mimic metastatic breast cancer (Clin Breast Cancer 2007;7:804)

 

End of Breast – Malignant, Males, Children > Breast cancer - spread and metastases

 

 

This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must also be interpreted in the context of a patient's clinical data using reasonable medical judgment.  This website should not be used as a substitute for the advice of a licensed physician.

 

All information on this website is protected by Copyright, (c) 2001-2009, PathologyOutlines.com, Inc.  Information from third parties may also be protected by copyright.  Please contact us at copyrightPathOut@gmail.com with any questions.